Transcriptomic analysis of bone marrow specimens collected from Miniature Dachshunds diagnosed with non-neoplastic bone marrow disorders

• Published in: Journal of Veterinary Medical Science 2024, Vol.86(7), pp.737-743
• Main Authors: TANI, Akiyoshi, NAKASE, Kota, TOMIYASU, Hirotaka, NEO, Sakurako, OHMI, Aki, GOTO-KOSHINO, Yuko, OHNO, Koichi, TSUJIMOTO, Hajime
• Format: Article
• Language: English
• Subjects: Animals; Blood cells; Bone marrow; Bone Marrow - pathology; Bone Marrow Diseases - genetics; Bone Marrow Diseases - pathology; Bone Marrow Diseases - veterinary; bone marrow disorder; canine; Cell activation; Dog Diseases - genetics; Dog Diseases - pathology; Dogs; Female; gene expression profile; Gene Expression Profiling - veterinary; Internal Medicine; Male; Miniature Dachshund; Myelodysplastic syndrome; Myelodysplastic Syndromes - genetics; Myelodysplastic Syndromes - pathology; Myelodysplastic Syndromes - veterinary; Pathophysiology; Peripheral blood; Signal transduction; Transcriptome; Transcriptomics; Wnt protein; Wnt signaling; Wnt Signaling Pathway
• ISSN: 0916-7250; 1347-7439; 1347-7439
• DOI: 10.1292/jvms.23-0371

Non-neoplastic bone marrow disorders are main causes of non-regenerative anemia in dogs. Despite the high incidence of the diseases, their molecular pathophysiology has not been elucidated. We previously reported that Miniature Dachshund (MD) was a predisposed breed to be diagnosed with non-neoplastic bone marrow disorders in Japan, and immunosuppressive treatment-resistant MDs showed higher number of platelets and morphological abnormalities in peripheral blood cells. These data implied that treatment-resistant MDs might possess distinct pathophysiological features from treatment-responsive MDs. Therefore, we conducted transcriptomic analysis of bone marrow specimens to investigate the pathophysiology of treatment-resistant MDs. Transcriptomic analysis comparing treatment-resistant MDs and healthy control dogs identified 179 differentially expressed genes (DEGs). Pathway analysis using these DEGs showed that “Wnt signaling pathway” was a significantly enriched pathway. We further examined the expression levels of DEGs associated with Wnt signaling pathway and confirmed the upregulation of AXIN2 and CCND2 and the downregulation of SFRP2 in treatment-resistant MDs compared with treatment-responsive MDs and healthy control dogs. This alteration implied the activation of Wnt signaling pathway in treatment-resistant MDs. The activation of Wnt signaling pathway has been reported in human patients with myelodysplastic syndrome (MDS), which is characterized by dysplastic features of blood cells. Therefore, the results of this study implied that treatment-resistant MDs have distinct molecular pathological features from treatment-responsive MDs and the pathophysiology of treatment-resistant MDs might be similar to that of human MDS patients.